Author

M. S. van der Heijden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:statistical model· 4 Assay:bulk RNA-seq· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2 Assay:whole-genome sequencing· 2 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

N. Mehra· 3 shared R. de Wit· 3 shared A. A. M. van der Veldt· 2 shared A. Gil-Jimenez· 2 shared H. J. G. van de Werken· 2 shared H. M. Westgeest· 2 shared J. A. Nakauma-Gonzalez· 2 shared J. L. Boormans· 2 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

N. Mehra

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologybioRxivMay 25, 2023

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors

A. Gil-Jimenez, N. van Dijk, J. L. Vos…·L. F. A. Wessels

DOI 10.1038/s41467-024-46450-1

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 30, 2022

T Cell-to-Stroma Enrichment (TSE) score: a gene expression metric that predicts response to immune checkpoint inhibitors in patients with urothelial cancer

M. M. Rijnders, J. A. Nakauma-Gonzalez, D. G. J. Robbrecht…·M. P. Lolkema

DOI 10.1101/2022.05.30.493997

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivMar 17, 2021

Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma

J. A. Nakauma-Gonzalez, M. Rijnders, J. van Riet…·J. L. Boormans

This paper identifies genomic and transcriptomic subtypes of metastatic urothelial carcinoma using multi-omics analysis, revealing potential therapeutic targets and patient-specific strategies.

DOI 10.1016/j.eururo.2022.01.026

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivOct 7, 2019

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

L. F. van Dessel, J. van Riet, M. Smits…·M. P. Lolkema

This study uses whole-genome sequencing to identify four distinct genotypes in metastatic castration-resistant prostate cancers, with potential clinical implications for patient stratification.

DOI 10.1038/s41467-019-13084-7

humanwhole-genome sequencing

𝕏 PostBluesky